EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Microbial Primer: The R-pyocins of Pseudomonas aeruginosa

Isaac Estrada, Parker Smith, Madeline Mei, Joanna B Goldberg, Stephen P Diggle

Microbiology · 2025

DOI: 10.1099/mic.0.001640 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Microbiology, 2025. Verfasst von Isaac Estrada und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center for Microbial Dynamics & Infection, School of Biological Sciences, Georgia Institute of Technology, Atlanta, GA, USA. Hauptthemen laut MEDLINE: Pseudomonas aeruginosa, Pyocins, Anti-Bacterial Agents. Die Arbeit wurde bisher 8-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

R-pyocins are phage tail-like protein complexes produced by Pseudomonas aeruginosa that deliver a single, lethal hit by depolarizing the target cell membrane. Unlike phages, R-pyocins lack capsids and DNA, and their killing is highly specific, being determined by tail fibre proteins that recognize subtype-specific LPS receptors on susceptible strains. Five known subtypes (R1–R5) vary in host range, with R5 displaying the broadest activity. R-pyocin expression is tightly regulated by the SOS response, linking their release to environmental stress. Their non-replicative mechanism and metabolic independence make them especially promising for targeting multidrug-resistant and biofilm-associated P. aeruginosa infections, such as those seen in cystic fibrosis and chronic wounds. Preclinical studies support their therapeutic potential, and bioengineering approaches have extended their target range. With their high specificity, rapid action and adaptability, R-pyocins are strong candidates for next-generation precision antimicrobials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pseudomonas aeruginosaPyocinsAnti-Bacterial AgentsPseudomonas InfectionsHumansBiofilmsHost Specificity

Stichwörter der Autor:innen

Pseudomonas aeruginosaR-pyocinsbacteriocinsphage tail-like bacteriocinstailocins

Substanzen

PyocinsAnti-Bacterial Agents

Autor:innen und Institutionen

  • Center for Microbial Dynamics & Infection, School of Biological Sciences, Georgia Institute of Technology, Atlanta, GA, USA.
  • Division of Pulmonary, Asthma, Cystic Fibrosis and Sleep, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.

Förderung

  • NIAID NIH HHS
  • Division of Intramural Research, National Institute of Allergy and Infectious Diseases
  • National Science Foundation
  • Cystic Fibrosis Foundation
  • Cystic Fibrosis Research

Zitieren

APA

Estrada, I., Smith, P., Mei, M., Goldberg, J. B., & Diggle, S. P. (2025). Microbial Primer: The R-pyocins of Pseudomonas aeruginosa. Microbiology. https://doi.org/10.1099/mic.0.001640

Vancouver

Estrada I, Smith P, Mei M, Goldberg JB, Diggle SP. Microbial Primer: The R-pyocins of Pseudomonas aeruginosa. Microbiology. 2025. doi:10.1099/mic.0.001640

BibTeX
@article{Estrada2025,
  author = {Estrada, Isaac and Smith, Parker and Mei, Madeline and Goldberg, Joanna B and Diggle, Stephen P},
  title = {Microbial Primer: The R-pyocins of Pseudomonas aeruginosa},
  journal = {Microbiology},
  year = {2025},
  doi = {10.1099/mic.0.001640}
}
Kostenlos starten →